122 related articles for article (PubMed ID: 4820552)
1. [Tay-Sachs' disease].
Clausen J; Melchior JC
Ugeskr Laeger; 1974 Feb; 136(6):305. PubMed ID: 4820552
[No Abstract] [Full Text] [Related]
2. Approaches to the control and prevention of Tay-Sachs disease.
Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
[TBL] [Abstract][Full Text] [Related]
3. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
Rogers JF; Hogan EL; Jorgenson RJ
South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
[TBL] [Abstract][Full Text] [Related]
4. A screening program for Tay-Sachs disease in Israel.
Padeh B
Isr J Med Sci; 1973; 9(9):1330-4. PubMed ID: 4775113
[No Abstract] [Full Text] [Related]
5. The fetal aspects of Tay-Sachs disease.
Schneck L; Adachi M; Volk BW
Pediatrics; 1972 Mar; 49(3):342-51. PubMed ID: 4334559
[No Abstract] [Full Text] [Related]
6. [Detection of carriers of Tay-Sachs disease by determining blood N-acetylhexosaminadase A activity].
Tsvetkova IV; Kozina AB
Vopr Med Khim; 1974; 20(6):631-4. PubMed ID: 4450529
[No Abstract] [Full Text] [Related]
7. Heterozygote detection for autosomal recessive genetic diseases. Community aspects of the Tay-Sachs experience.
Jackson LG
Clin Pediatr (Phila); 1974 Apr; 13(4):307-9. PubMed ID: 4821814
[No Abstract] [Full Text] [Related]
8. Automated thermal fractionation of serum hexosaminidase: effects of alteration in reaction variables and implications for Tay-Sachs disease heterozygote screening.
Kaback MM; Bailin G; Hirsch P; Roy C
Prog Clin Biol Res; 1977; 18():197-212. PubMed ID: 23554
[No Abstract] [Full Text] [Related]
9. Tay-Sachs disease heterozygote detection: a quality control study.
Kaback MM; Shapiro LJ; Hirsch P; Roy C
Prog Clin Biol Res; 1977; 18():267-79. PubMed ID: 601080
[No Abstract] [Full Text] [Related]
10. Screening for carriers of Tay-Sachs disease: A community project.
Lowden JA; Zuker S; Wilensky AJ; Skomorowski MA
Can Med Assoc J; 1974 Aug; 111(3):229-33. PubMed ID: 4854206
[TBL] [Abstract][Full Text] [Related]
11. Community screening for Tay-Sachs disease.
Jackson LG; Nimoityn P; Faust HS; Glazerman LR
Am Fam Physician; 1976 Apr; 13(4):111-4. PubMed ID: 1266700
[TBL] [Abstract][Full Text] [Related]
12. Tay-Sachs heterozygote screening: specificity and sensitivity.
Scriver CR; Gold RJ
Prog Clin Biol Res; 1977; 18():239-43. PubMed ID: 601079
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on screening and prevention of Tay-Sachs disease in Israel.
Padeh B; Shacher S; Katznelson MB; Navon R; Goldman B
Prog Clin Biol Res; 1977; 18():47-53. PubMed ID: 601094
[No Abstract] [Full Text] [Related]
14. Letter: Testing for Tay-Sachs heterozygotes.
Edwards JH
Lancet; 1973 Nov; 2(7838):1143-4. PubMed ID: 4128027
[No Abstract] [Full Text] [Related]
15. Testing for the Tay-Sachs gene in the Atlanta Jewish population.
Marion JP; Danner DJ; Ballou WR; Marion R; Elsas LJ
South Med J; 1977 Jul; 70(7):833-7. PubMed ID: 877647
[TBL] [Abstract][Full Text] [Related]
16. Tay-Sachs' retina. Deficiency of acetyl hexosaminidase A.
Cotlier E
Arch Ophthalmol; 1971 Sep; 86(3):352-6. PubMed ID: 5095559
[No Abstract] [Full Text] [Related]
17. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
[No Abstract] [Full Text] [Related]
18. [Tay-Sachs disease].
Okada S
Nihon Rinsho; 1973 Aug; 31(8):2463-8. PubMed ID: 4588056
[No Abstract] [Full Text] [Related]
19. Studies on brain lipids in Tay-Sachs' disease. III. Solubility properties of gangliosides.
GATT S; BERMAN ER
J Neurochem; 1963 Feb; 10():65-72. PubMed ID: 13946798
[No Abstract] [Full Text] [Related]
20. Studies on brain lipids in Tay-Sachs' disease. II. Solubility properties of gangliosides.
GATT S; BERMAN ER
J Neurochem; 1963 Feb; 10():65-72. PubMed ID: 13946797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
